Ocean Biomedical Statistics
Share Statistics
Ocean Biomedical has 34.82M shares outstanding. The number of shares has increased by 226.88% in one year.
| Shares Outstanding | 34.82M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 10.38M |
| Failed to Deliver (FTD) Shares | 4.63K |
| FTD / Avg. Volume | 9.09% |
Short Selling Information
The latest short interest is 165.46K, so 0.48% of the outstanding shares have been sold short.
| Short Interest | 165.46K |
| Short % of Shares Out | 0.48% |
| Short % of Float | 1.62% |
| Short Ratio (days to cover) | 2.64 |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is -0.83.
| PE Ratio | 0 |
| Forward PE | -0.83 |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | n/a |
Enterprise Valuation
Ocean Biomedical Inc. has an Enterprise Value (EV) of -.
| EV / Earnings | null |
| EV / Sales | null |
| EV / EBITDA | null |
| EV / EBIT | null |
| EV / FCF | null |
Financial Position
The company has a current ratio of 0.07, with a Debt / Equity ratio of -0.13.
| Current Ratio | 0.07 |
| Quick Ratio | 0.07 |
| Debt / Equity | -0.13 |
| Total Debt / Capitalization | -15.41 |
| Cash Flow / Debt | -0.78 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is null% and return on capital (ROIC) is 3.16%.
| Return on Equity (ROE) | null% |
| Return on Assets (ROA) | null% |
| Return on Capital (ROIC) | 3.16% |
| Revenue Per Employee | 0 |
| Profits Per Employee | 62.83K |
| Employee Count | 9 |
| Asset Turnover | null |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 11% in the last 52 weeks. The beta is 1.53, so Ocean Biomedical 's price volatility has been higher than the market average.
| Beta | 1.53 |
| 52-Week Price Change | 11% |
| 50-Day Moving Average | 0.83 |
| 200-Day Moving Average | 1.53 |
| Relative Strength Index (RSI) | 34.52 |
| Average Volume (20 Days) | 50.91K |
Income Statement
In the last 12 months, Ocean Biomedical had revenue of $0 and earned $565.47K in profits. Earnings per share was $-0.03.
| Revenue | 0 |
| Gross Profit | 0 |
| Operating Income | -2.48M |
| Net Income | 565.47K |
| EBITDA | -957.74K |
| EBIT | - |
| Earnings Per Share (EPS) | -0.03 |
Balance Sheet
The company has $4.00K in cash and $12.12M in debt, giving a net cash position of -$12.11M.
| Cash & Cash Equivalents | 4.00K |
| Total Debt | 12.12M |
| Net Cash | -12.11M |
| Retained Earnings | -196.06M |
| Total Assets | 5.50M |
| Working Capital | -27.90M |
Cash Flow
In the last 12 months, operating cash flow was -$9.43M and capital expenditures $0, giving a free cash flow of -$9.43M.
| Operating Cash Flow | -9.43M |
| Capital Expenditures | 0 |
| Free Cash Flow | -9.43M |
| FCF Per Share | 0 |
Margins
Gross margin is 0%, with operating and profit margins of 0% and 0%.
| Gross Margin | 0% |
| Operating Margin | 0% |
| Pretax Margin | 0% |
| Profit Margin | 0% |
| EBITDA Margin | n/a% |
| EBIT Margin | n/a% |
| FCF Margin | n/a% |
Dividends & Yields
OCEA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -4.62% |
| FCF Yield | -41.66% |
Analyst Forecast
Currently there are no analyst rating for OCEA.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | -98.96 |
| Piotroski F-Score | 2 |